hotspot -WSS

hotspot

author：focus 2025-09-30 08:49:51 - browse：4848

Gene therapy helped Conner Curran, right, walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. -- Biotech coverage from STAT — Gene therapy helped Conner Curran (at right) walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. Courtesy Jess & Chris Curran

In the beginning, Conner Curran ran up the stairs.

It was a miraculous moment for him and his parents, Jess and Chris Curran. Just months before, contractors were in their New York home to install a motorized lift, while Jess tearfully explained that it wasn’t for a grandparent but for their 7-year-old son, who suffered from Duchenne muscular dystrophy and could barely haul himself up the steps.

Then Conner was accepted as the first patient in Pfizer’s Duchenne gene therapy trial. Three weeks later, he could bound to the second floor. Soon, he could walk the two-plus miles to Goldberg’s, a local bagel shop. “I couldn’t do that before,” he told NPR in 2020.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： After a drawn out lobbying fight, ARPA

WSS

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Inequities make cancer less preventable for women: report

Results on Novartis prostate cancer therapy could expand its use

Address the ethical violations that led to 'Three Identical Strangers'

FDA advisers vote against ALS treatment from BrainStorm

Wikipedia

hotspot

explore

Peter Hotez and the public health issue of online harassment

Inequities make cancer less preventable for women: report

In Memoriam: Notable people who died in 2023

STAT Summit: Ending the crisis of Black deaths in the U.S.

Apple is now the first public company to be valued at $3 trillion

Paxlovid should be available without a positive Covid test

After affirmative action ruling, medical educators look to 'holistic review'

STAT Readout: Friday, Oct. 20 biotech updates

23andMe had bad news about my health. I wish a person had delivered it

Why a market frenzy over new weight loss drugs defies logic

Wikipedia

After a drawn out lobbying fight, ARPA

Senator probes 340B programs at Cleveland Clinic, Bon Secours

ADCs take center stage as promising cancer treatments

Study on Amgen’s bispecific immunotherapy produces positive data

ADCs take center stage as promising cancer treatments

Is there really a nursing shortage in the U.S.?

explore

hotspot

explore

hotspot